You are here:


AOP Orphan Contact

AOP Orphan worldwide

Wilhelminenstraße 91/IIf
1160 Vienna, Austria
office(at)aoporphan.com

Rare Diseases: AOP Orphan Pharmaceuticals AG invests in sustainable Research & Development


An interview with Dr Rudolf Widmann, CEO and Dr Christoph Klade, CSO about AOP Orphan’s commitment to sustainable innovation for the benefit of patients with rare diseases and Austria as a research location was published recently in CURE, a special edition insert for the Austrian newspaper “derStandard”.

To read the full article in German, please click here